Abstract The 2017 World Health Organization (WHO) classification proposes to type and
subtype primary adenohypophyseal tumours according to their cell lineages with the aim to …

Adenohypophyseal tumors, which were recently renamed pituitary neuroendocrine tumors
(PitNET), are mostly benign, but may present various behaviors: invasive,“aggressive” and …

In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central
Nervous System Tumours, pituitary adenomas are reclassified as neuroendocrine tumours …

The 4th edition of the World Health Organization (WHO) classification of endocrine tumors
has been recently released. In this new edition, major changes are recommended in several …

Abstract The WHO Classification of Endocrine Tumours designates pituitary neoplasms as
adenomas. A proposed nomenclature change to pituitary neuroendocrine tumors (PitNETs) …

This review focuses on discussing the main changes on the upcoming fourth edition of the
WHO Classification of Tumors of the Pituitary Gland emphasizing histopathological and …

The classification of neoplasms of adenohypophysial cells is misleading because of the
simplistic distinction between adenoma and carcinoma, based solely on metastatic spread …

Neuroendocrine tumours of the adenohypophysis have traditionally been designated as
pituitary adenomas to underline their usually indolent growth and lack of metastatic …

Pituitary tumors are very complex and heterogeneous and have a very wide range of
proliferative and aggressive behaviors, and how to define and classify these tumors remains …

The classification of adenohypophysial neoplasms as “pituitary neuroendocrine
tumors”(PitNETs) was proposed in 2017 to reflect their characteristics as epithelial …